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Abstract: Retroviruses like HIV-1 and HTLV-1 can be transmitted efficiently by direct 
contact between infected and target cells. For HIV-1, various modes of cell-to-cell transfer 
have been reported, including virological synapses, polysynapses, filopodial bridges, and 
nanotube-like structures. So far, only synapses and biofilms have been described for 
HTLV-1 transmission. Recently, Van Prooyen et al. [1] identified an additional mode of 
HTLV-1 transmission through cellular conduits induced by the viral accessory protein p8. 
Keywords: HTLV-1; HIV-1; cell-to-cell transfer; virological synapses; cellular conduits; 
p8; p12; Nef 
 
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell 
leukemia/lymphoma (ATLL), a rare but aggressive T-cell lymphoproliferation. Infection by HTLV-1 
is also associated with tropical spastic parapesis/HTLV-1-associated myelopathy (TSP/HAM), a 
neurological disorder. This retrovirus is barely secreted from infected cells, but is efficiently 
transmitted by cell/cell contacts such as virological synapses (VS) [2,3] or polysynapses (PS) [1], and 
propagates by clonal expansion of infected T cells. Like many other retroviruses, HTLV-1 encodes 
regulatory (HBZ, Tax, Rex) and accessory (p12, p13, p30) proteins. It has been previously shown that 
p12, which is encoded by the orf-I gene, can be cleaved in the endoplasmic reticulum (ER) to generate 
p8, a membrane-associated protein [4]. Many different activities have been reported for p8 and p12, 
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but the specific contributions of these two proteins are still unclear. A recent article by the team of 
Genoveffa Franchini provides novel insights into the role of these proteins and reports that p8 
increases HTLV-1 cell-to-cell transmission through the formation of cellular conduits [1]. 
To investigate the role of p12 and p8 in HTLV-1 transmission, Van Prooyen et al. [1] transfected 
cells with WT, p8/p12-deleted HTLV-1, or with plasmids expressing p8 or an uncleavable form of 
p12. They show that expression of p8, but not that of the uncleavable variant of p12, rescues 
p8/p12-deleted virus infectivity defect. p8 is recruited at the cell membrane and colocalizes with 
lymphocyte function-associated antigen-1 (LFA-1). Even if p8 does not affect LFA-1 surface levels, it 
increases its clustering at the cell surface which results in an increase of T-cell adhesion, conjugate 
formation and HTLV-1 transmission. Coculture experiments demonstrated that p8 increases the 
number and the length of cellular conduits. Furthemore, p8 overexpression in a chronically HTLV-1 
infected cell line increases polysynapses formation and viral transmission. In addition to Gag, p8 is 
also transferred to neighboring cells through these conduits. The authors conclude that HTLV-1 can be 
transmitted upon contact with the target cell, via the virological synapse, and through cellular conduits. 
They propose a model in which p8 would enhance viral transfer, and at the same time invade target 
cells to protect them from immune recognition (Figure 1). 
Figure 1. Hypothetical model for p8 and p12 action (from [1]). In infected cells, p8 
decreases T cell receptor (TCR) proximal signaling, major histocompatibility complex type 
I (MHC-I) expression at the cell surface, and increases lymphocyte function-associated 
antigen-1 (LFA-1) clustering. These events result in low viral production, evasion from 
immune recognition by NK cells and CD8
+
 T cells (CTL) and recruitment of non-infected 
cells, respectively. p8 induces the formation of cellular conduits, allowing rapid transfer of 
the virus and of p8 itself into target cells. In newly infected cells, p8 promotes anergy and 
contributes further to immune evasion. This model provides clues for understanding the 
mechanism of HTLV-1 persistence in the infected host. 
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This work suggests the existence of a new mode of HTLV-1 transmission mediated by p8, and 
reconciles some contradictory observations concerning the p8/p12 proteins. However, the molecular 
mechanism by which p8 promotes HTLV-1 transmission remains unknown. Especially, it remains 
unclear whether p8-mediated increase of viral transmission is mediated by (i) cellular conduits, as 
suggested by the authors (ii) transfer through virological synapses and polysynapses (iii) syncytia, as 
proposed by Taylor et al. [5] or (iv) through “viral biofilms” [6]. Moreover, this study relies mostly on 
protein overexpression in a cell line model. It will be important to confirm the relevance of these 
results in primary T cells, using viruses deleted for p8 or p12 only, rather than complementing  
p12-deleted viruses with overexpressed p8 or p12. Finally, it has been previously demonstrated that p8 
is present in lipid rafts and colocalizes with the immune synapse (IS), where it down-regulates 
expression of several proteins such as Major Histocompatibility Complex type I (MHC-I) and T cell 
receptor (TCR). Thus, it would be of great interest to determine if p8 is also present at the site of the 
VS and influences viral transfer. 
Like HTLV-1, Human immunodeficiency virus type 1 (HIV-1) is transferred directly from cell to 
cell, using filopodes, nanotubes, VS and PS. Interestingly, the features of p8 are highly reminiscent of 
those of the HIV-1 Nef protein (Table 1). 
Table 1. Comparison of HIV-1 Nef and HTLV-1 p8/12 main functions. 
Functions Nef p8/p12 
Increase of infectivity in vitro + [7] + [8] 
Required for infection in vivo + [9] + [10] 
TCR down-regulation  + [11] + [12] 
MHC-I down-regulation  + [13] + [14] 
Increase of IL-2 production + [15] + [16] 
Immune synapse modulation + [11] + [4] 
Increase of viral cell-to-cell transmission +/− [17] + [1] 
Induction of membrane extensions + [18] + [1] 
Syncytia formation [19]   [5] 
Polysynapse formation ? + [1] 
ICAM 1-2 down-regulation  ? + [20] 
LFA-1 clustering ? + [21] 
 
HTLV-1 and HIV-1 use viral synapses to promote efficient transmission. They both encode one 
accessory protein present in the lipid rafts, targeting similar cellular functions, such as MHC-I and 
TCR down-regulation, and impairment of immune synapse formation. Both Nef and p8 induce the 
formation of membrane extensions, which may allow them to be transferred to target cells. Nef, for 
instance induces the formation of intercellular conduits bridging infected macrophages to bystander B 
lymphocytes (LB). Nef is then transferred to LB and inhibits IgG2 and IgA class switching [22]. Nef 
also promotes the formation of filopodia [18], but probably not that of nanotubes, an event independent 
of HIV infection [23]. In the present work, the authors show that p8 increases the number and length of 
cellular conduits and is responsible for a four-fold increase of HTLV-1 transmission. Therefore, it is 
tempting to speculate that Nef may have similar effects on HIV-1 cell-to-cell transmission. However, a 
recent report indicates that this is not the case [17]. 
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Nef and p8/p12 appear to be dispensable for in vitro propagation. In contrast, viruses deleted for 
these proteins replicate less efficiently in non-human primates [9,10]. The in vivo relevance of the 
results described by Van Prooyen et al. [1] remains thus to be established. For instance, it has been 
proven difficult to detect p8 at the protein level in HTLV-1 infected cells, and Fukumoto et al. reported 
a predominance of alleles encoding uncleavable forms of p12 in a cohort of HTLV-1-infected patients 
[4]. More work is therefore required to confirm the importance of p8 in viral transmission in vivo. 
Overall, this work identifies a new mode of HTLV-1 transmission using cellular conduits induced 
by the viral protein p8. To gain further insight into HTLV-1 transmission and pathogenesis, it will be 
worth better characterizing the specific functions of p8 and p12 in vitro and in vivo and identifying the 
cellular proteins involved in this new mechanism. Since HIV-1 Nef and HTLV-1 p8 share common 
features, it will be of interest to determine if these two proteins interact with the same host proteins to 
mediate their effects on viral replication. 
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